期刊文献+

阿托伐他汀钙对缺血性脑血管病复发的影响 被引量:1

The effects of Atorvastatin on recurrence of ischemic cerebrovascular disease
下载PDF
导出
摘要 目的研究阿托伐他汀钙对缺血性脑血管病复发的影响。方法将78例首发缺血性脑血管病病人分为治疗组45例和对照组33例,对照组服用阿司匹林100mg,每天1次;治疗组加用阿托伐他汀钙20mg,每晚1次,追踪1年,观察两组病人缺血性脑血管病的复发率和不良反应。结果治疗组45例1年复发率17.8%,明显低于对照组的48.5%(χ2=2.4971,P<0.05)。结论阿托伐他汀钙对缺血性脑血管病复发有明确的预防效果。 Objective To study the effects of Atorvastatin on recurrence of ischemic cerebrevascular disease. Methods 78 patients with ischemic cerebrovascular disease were divided into the treatment group ( n = 45 ) and the control group ( n = 45 ), and the control group used aspirin 100mg once every day, the treatment group used Atorvastatin 20rag once every night. Recurrence of ischemic cerebrovascular disease and complications were investigated for one year. Results The rate of the recurrence of ischemic cerebrevascular disease in the treatment group ( 17.8% ) was lower than that in the control group. Conclusion Atorvastat is effective to prevent the recurrence of ischemic cerebrevascular disease.
出处 《宁夏医学杂志》 CAS 2009年第5期433-434,共2页 Ningxia Medical Journal
基金 银川市科委资助项目
关键词 阿托伐他汀钙 缺血性脑血管病 Atorvastatin lschemic cerebrovascular disease
  • 相关文献

参考文献7

  • 1马虹 黄洁夫.降脂药-HMG-CoA还原酶抑制剂.临床医生用药大全,2003,(65):625-627.
  • 2Sever PS,Daholf B,Pouter NF,et al.Prevention of coronary and stroke events with atorvastatoin in hypertention patients who have anerage or lower 2 than average cholesterol concentrations in the Anglo-Scanolinavian Cardiac Outcomes Trial-lipid Lowering Arm(ASCOT-LLA):a ulticentre randomized controlled trial[J].Lancet,2003,361(9364):1147-1158.
  • 3Athyros VG,Papgeogiou AA,Mercouris BR,et al.Treatment with atovastatin to the National Cholesterol Educational Program goal versus usual care in secondary coronary heart disease Evaluation(GREACE) Study[J].Curr Med Opin,2002,18(4),220-228.
  • 4Heart Pretection Study Colleborative Group.MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high 2 risk individuals a randomized placebo 2 controlled Trial[J].Lancet,2002,360(9326):7-22.
  • 5Shepherd J,Blauw GJ,Murphy,MB,et al.Pravastatin in elderlyindividuals at risk of vascular disease(PROSPER):a randomizedcontrolledtrial[J].Lancet,2002,360(9346):1623-1630.
  • 6何熹延,何吟绵,娄彬,谷明林.他汀类药物在心脑血管疾病中应用进展[J].临床荟萃,2004,19(1):48-51. 被引量:26
  • 7彭斌,崔丽英.他汀类药物预防卒中机制[J].中国卒中杂志,2009,4(1):49-52. 被引量:1

二级参考文献16

  • 1范维琥.他汀类药物及其非降脂作用疗效评价[J].临床新视点,2002,(1):9-9.
  • 2宁育.心衰治疗新策略[J].中国医学论坛报,2002,28(41):30-30.
  • 3诸骏仁.调脂治疗的趋势[J].临床新视点,2002,(1):1-2.
  • 4.
  • 5Tunon J,Marti-n-Ventura JL,Blanco-Colio LM,et al.Mechanisms of action of statins in stroke[].Expert OpinTher Targets.2007
  • 6Notarbartolo A,Davi G,Averna M,et al.Inhibition of thromboxane biosynthesis and platelet function by simvastatin in Type Iia hypercholesterolemia[].Arteriosclerosis Thrombosis and Vascular Biology.1995
  • 7Tunon J,Marti-n-Ventura JL,Blanco-Colio LM,et al.Mechanisms of action of statins in stroke[].Exp:ert OpinTher Targets.2007
  • 8Chen Z,Fukutomi T,Zago AC,et al.Simvastatin reduces neointimal thickening in low-density lipoprotein receptor-deficient mice after experimental angioplasty without changing plasma lipids[].Circulation.2002
  • 9MacMahon,S.Blood pressure and the prevention of stroke[].Journal of Hypertension.1996
  • 10Atkins,D,Psaty,BM,Koepsell,TD.Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials[].Annals of Internal Medicine.1993

共引文献25

同被引文献29

引证文献1

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部